Benztropine-fig-01 (69c6013b C977 409a B03b 1ecd473e6846 01)
Benztropine Mesylate Injection
Product Images NDC 68475-512
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Benztropine Mesylate (NDC 68475-512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image-3 (69c6013b C977 409a B03b 1ecd473e6846 02)
This is a description of a medication in the form of an injection. The medication is Benztropine Mesylate with a concentration of 2mg/2mL (1mg/mL) and is stored at a controlled room temperature of 20° to 25°C (68° to 77°F). The injection is intended for intravenous or intramuscular use and comes in a 2mL single-dose vial. The manufacturing company is Navinta LLC.*
Impage-2 (69c6013b C977 409a B03b 1ecd473e6846 03)
Benztropine Mesylate is a medication used for Parkinsonism and drug-induced extrapyramidal disorders. Each milliliter contains 1mg of USP Benztropine Mesylate and inactive ingredients such as 9mg Sodium Chloride USP and water for injection. The usual adult dosage is 1 to 2mg daily for Parkinsonism and 1-4mg once or twice daily for drug-induced extrapyramidal disorders. It is manufactured by Navinta LLC and is available in 2mL single-dose vials. The accompanying package insert should be referred to for more information. The NDC code is 68475-512-02.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
